Evidence-based coverage of pharmaceutical development, regulatory affairs, and biotech innovation
In the fast-paced world of biotech, emerging companies are always looking for ways to stand out and make their mark. One key strategy they're using is to form strategic partnerships with other compani
By Dr. Eleanor Vance, Regulatory Affairs Editor
The pharmaceutical industry has seen a significant rise in the demand for biologics, which are drugs produced from living organisms. As the demand for biologics continues to grow, so does the need for
By Dr. Eleanor Vance, Regulatory Affairs Editor
The National Health Service (NHS) has recently introduced a new pharmacy plan aimed at reducing the length of stay for patients in hospitals. The plan seeks to streamline the discharge process for pat
By Priya Raghavan, Biotech & Markets Analyst
After 13 years of research, Dr David Sinclair and his team have made a breakthrough discovery regarding ageing. Sinclair, a genetics professor at Harvard Medical School and co-director of the Paul F.
By Dr. Eleanor Vance, Regulatory Affairs Editor
Lymphoma cancer is a type of cancer that affects the lymphatic system, which is responsible for fighting infections and diseases. While there are several types of lymphoma, the two main categories are
By Tom Okafor, Clinical Trials Correspondent
In the highly competitive world of pharmaceuticals, companies are constantly looking for the next big breakthrough drug. The quest for new treatments can be a risky and expensive endeavour, with no gu
By Tom Okafor, Clinical Trials Correspondent
Cervical cancer is one of the main reasons women die, but it can be stopped if it is found and treated early. In recent years, much progress has been made in the fight against cervical cancer, with th
By Tom Okafor, Clinical Trials Correspondent
Following the worldwide COVID-19 outbreak, the pharmaceutical industry faces both potential and increased complications. In the near future, there are a few important things for pharma to keep an eye
By Priya Raghavan, Biotech & Markets Analyst
Years of preclinical and clinical trials on mRNA vaccines for cancer therapy have laid the groundwork for making mRNA vaccines during the COVID-19 pandemic. The inherent benefit of ease of production,
By Tom Okafor, Clinical Trials Correspondent
Researchers claim to have made progress in developing a vaccine that will protect against all 20 forms of influenza. The effective Covid vaccines employ the same messenger-ribonucleic acid (mRNA) tech
By Dr. Eleanor Vance, Regulatory Affairs Editor
It has been called "historic" that the first drug to slow the brain damage caused by Alzheimer's has been made. The scientific discovery puts a stop to decades of futility and demonstrates that new me
By Dr. Eleanor Vance, Regulatory Affairs Editor
It is still attempting to resolve the fundamental issue. In general, Mark Cuban's new online pharmacy is delivering on its promises of offering low savings on hundreds of prescription medications. The
By Priya Raghavan, Biotech & Markets Analyst
Subscribe to our weekly pharmaceutical intelligence digest
We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy